-
1
-
-
0034049874
-
Glucocorticoids in T cell development and function
-
Ashwell JD, Lu FW, Vacchio MS (2000) Glucocorticoids in T cell development and function. Annu Rev Immunol 18: 309-345
-
(2000)
Annu Rev Immunol
, vol.18
, pp. 309-345
-
-
Ashwell, J.D.1
Lu, F.W.2
Vacchio, M.S.3
-
4
-
-
22944458547
-
Plaque psoriasis vs. atopic dermatitis and lichen planus: A comparison for lesional T-cell subsets, epidermal proliferation and differentiation
-
Bovenschen HJ, Seyger MM, Van de Kerkhof PC (2005) Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation. Br J Dermatol 153:72-78
-
(2005)
Br J Dermatol
, vol.153
, pp. 72-78
-
-
Bovenschen, H.J.1
Seyger, M.M.2
Van de Kerkhof, P.C.3
-
5
-
-
16444375448
-
Selective persistence of dermal CD8+ T cells in lesional plaque psoriasis after clobetasol-17 propionate treatment
-
Bovenschen HJ, Vissers WH, Seyger MM, Van de Kerkhof PC (2005) Selective persistence of dermal CD8+ T cells in lesional plaque psoriasis after clobetasol-17 propionate treatment. Acta Derm Venereol 85:113-117
-
(2005)
Acta Derm Venereol
, vol.85
, pp. 113-117
-
-
Bovenschen, H.J.1
Vissers, W.H.2
Seyger, M.M.3
Van de Kerkhof, P.C.4
-
6
-
-
13844316466
-
Alefacept reduces in filtrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris
-
Chamian F, Lowes MA, Lin S-L, Lee E, Kikuchi T, Gilleaudeau P, Sullivan-Whalen M, Cardinale I, Khatcherian A, Novitskaya I, Wittkowski KM, Krueger JG (2005) Alefacept reduces in filtrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris. Proc Natl Acad Sci USA 102:2075-2080
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 2075-2080
-
-
Chamian, F.1
Lowes, M.A.2
Lin, S.-L.3
Lee, E.4
Kikuchi, T.5
Gilleaudeau, P.6
Sullivan-Whalen, M.7
Cardinale, I.8
Khatcherian, A.9
Novitskaya, I.10
Wittkowski, K.M.11
Krueger, J.G.12
-
7
-
-
0028958047
-
Effects of topical treatment with budesonide on parameters for epidermal proliferation, keratinization and inflammation in psoriasis
-
De Jong EM, Ferrier CM, de Zwart A, Wauben-Penris PJ, Korstanje C, Van de Kerkhof PC (1995) Effects of topical treatment with budesonide on parameters for epidermal proliferation, keratinization and inflammation in psoriasis. J Dermatol Sci 9:185-194
-
(1995)
J Dermatol Sci
, vol.9
, pp. 185-194
-
-
De Jong, E.M.1
Ferrier, C.M.2
de Zwart, A.3
Wauben-Penris, P.J.4
Korstanje, C.5
Van de Kerkhof, P.C.6
-
8
-
-
16444369820
-
Corticosteroids
-
Van de Kerkhof PCM ed, 2nd edn. Blackwell, Oxford
-
Eisman S, Rustin MH (2003) Corticosteroids. In: Van de Kerkhof PCM (ed) Textbook of psoriasis 2nd edn. Blackwell, Oxford
-
(2003)
Textbook of psoriasis
-
-
Eisman, S.1
Rustin, M.H.2
-
9
-
-
0035954670
-
Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes
-
Ellis CN, Krueger GG (2001) Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. N Engl J Med 345:248-255
-
(2001)
N Engl J Med
, vol.345
, pp. 248-255
-
-
Ellis, C.N.1
Krueger, G.G.2
-
10
-
-
0014985464
-
The effect of corticosteroids on human epidermal mitotic activity
-
Fisher LB, Maibach HI (1971) The effect of corticosteroids on human epidermal mitotic activity. Arch Dermatol 103:39-41
-
(1971)
Arch Dermatol
, vol.103
, pp. 39-41
-
-
Fisher, L.B.1
Maibach, H.I.2
-
11
-
-
0018099294
-
Severe psoriasis - oral therapy with a new retinoid
-
Frederiksson T, Petterson U (1978) Severe psoriasis - oral therapy with a new retinoid. Dermatologica 157:238-244
-
(1978)
Dermatologica
, vol.157
, pp. 238-244
-
-
Frederiksson, T.1
Petterson, U.2
-
12
-
-
2142711704
-
Alefacept therapy reduces the effector T-cell population in lesional psoriatic epidermis
-
Goedkoop AY, de Rie MA, Picavet DI, Kraan MC, Dinant HJ, van Kuijk AW, Tak PP, Bos JD, Teunissen MB (2004) Alefacept therapy reduces the effector T-cell population in lesional psoriatic epidermis. Arch Dermatol Res 295:465-473
-
(2004)
Arch Dermatol Res
, vol.295
, pp. 465-473
-
-
Goedkoop, A.Y.1
de Rie, M.A.2
Picavet, D.I.3
Kraan, M.C.4
Dinant, H.J.5
van Kuijk, A.W.6
Tak, P.P.7
Bos, J.D.8
Teunissen, M.B.9
-
13
-
-
0348134794
-
Treatment of psoriasis with alefacept. Correlation of clinical improvement with reductions of memory T-cell counts
-
Gordon KB, Vaishnaw AK, O'Gorman J, Haney J, Menter A (2003) Treatment of psoriasis with alefacept. Correlation of clinical improvement with reductions of memory T-cell counts. Arch Dermatol 139:1563-1570
-
(2003)
Arch Dermatol
, vol.139
, pp. 1563-1570
-
-
Gordon, K.B.1
Vaishnaw, A.K.2
O'Gorman, J.3
Haney, J.4
Menter, A.5
-
14
-
-
0142182716
-
CD4+ T-cell-directed antibody responses are maintained in patients with psoriasis receiving alefacept: Results of a randomized study
-
Gottlieb AB, Casale TB, Frankel E, Goffe B, Lowe N, Ochs HD, Roberts JL, Washenik K, Vaishnaw AK, Gordon KB (2003) CD4+ T-cell-directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized study. J Am Acad Dermatol 49:816-825
-
(2003)
J Am Acad Dermatol
, vol.49
, pp. 816-825
-
-
Gottlieb, A.B.1
Casale, T.B.2
Frankel, E.3
Goffe, B.4
Lowe, N.5
Ochs, H.D.6
Roberts, J.L.7
Washenik, K.8
Vaishnaw, A.K.9
Gordon, K.B.10
-
16
-
-
2142829675
-
Alefacept selectively reduces subpopulations of memory CD4+ and CD8+ T cells (Abstract)
-
Krueger JG, Gilleaudeau P, Kikuchi T, Lee E. (2002) Alefacept selectively reduces subpopulations of memory CD4+ and CD8+ T cells (Abstract). J Invest Dermatol 119:759
-
(2002)
J Invest Dermatol
, vol.119
, pp. 759
-
-
Krueger, J.G.1
Gilleaudeau, P.2
Kikuchi, T.3
Lee, E.4
-
17
-
-
0036145337
-
The immunologic basis for the treatment of psoriasis with new biologic agents
-
Krueger JG (2002) The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 46:1-23
-
(2002)
J Am Acad Dermatol
, vol.46
, pp. 1-23
-
-
Krueger, J.G.1
-
18
-
-
0037592156
-
Clinical response to alefacept: Results of a phase 3 study of intravenous administration of alefacept in patients with chronic plaque psoriasis
-
Krueger GG (2003) Clinical response to alefacept: results of a phase 3 study of intravenous administration of alefacept in patients with chronic plaque psoriasis. J Eur Acad Dermatol Venereol 2 (suppl 17):17-24
-
(2003)
J Eur Acad Dermatol Venereol
, vol.2
, Issue.SUPPL. 17
, pp. 17-24
-
-
Krueger, G.G.1
-
19
-
-
0036895587
-
-
Krueger GG, Papp KA, Stough DB, Loven KH, Gulliver WP, Ellis CN; Alefacept Clinical Study Group (2002) A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis. J Am Acad Dermatol 47:821-833
-
Krueger GG, Papp KA, Stough DB, Loven KH, Gulliver WP, Ellis CN; Alefacept Clinical Study Group (2002) A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis. J Am Acad Dermatol 47:821-833
-
-
-
-
20
-
-
0038385972
-
-
Lebwohl M, Christophers E, Langley R, Ortonne JP, Roberts J, Griffiths CE; Alefacept Clinical Study Group (2003) An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis. Arch Dermatol 139:719-727
-
Lebwohl M, Christophers E, Langley R, Ortonne JP, Roberts J, Griffiths CE; Alefacept Clinical Study Group (2003) An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis. Arch Dermatol 139:719-727
-
-
-
-
21
-
-
0028351526
-
Mechanism of lymphocyte function-associated molecule 3-Ig fusion proteins inhibition of T cell responses. Structure/ function analysis in vitro and in human CD2 transgenic mice
-
Majeau GR, Meier W, Jimmo B, Kioussis D, Hochman PS (1994) Mechanism of lymphocyte function-associated molecule 3-Ig fusion proteins inhibition of T cell responses. Structure/ function analysis in vitro and in human CD2 transgenic mice. J Immunol 152:2753-2767
-
(1994)
J Immunol
, vol.152
, pp. 2753-2767
-
-
Majeau, G.R.1
Meier, W.2
Jimmo, B.3
Kioussis, D.4
Hochman, P.S.5
-
22
-
-
0027163180
-
Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses
-
Miller GT, Hochman PS, Meier W, Tizard R, Bixler SA, Rosa MD, Wallner BP (1993) Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses. J Exp Med 178:211-222
-
(1993)
J Exp Med
, vol.178
, pp. 211-222
-
-
Miller, G.T.1
Hochman, P.S.2
Meier, W.3
Tizard, R.4
Bixler, S.A.5
Rosa, M.D.6
Wallner, B.P.7
-
23
-
-
0032847323
-
The immunologic and genetic basis of psoriasis
-
Nickoloff BJ (1999) The immunologic and genetic basis of psoriasis. Arch Dermatol 135:1104-10
-
(1999)
Arch Dermatol
, vol.135
, pp. 1104-1110
-
-
Nickoloff, B.J.1
-
24
-
-
0033748019
-
Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model
-
Nickoloff BJ, Bonish B, Huang BB, Porcelli SA (2000) Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model. J Dermatol Sci 24:212-225
-
(2000)
J Dermatol Sci
, vol.24
, pp. 212-225
-
-
Nickoloff, B.J.1
Bonish, B.2
Huang, B.B.3
Porcelli, S.A.4
-
25
-
-
0037930034
-
Clinical response to alefacept: Results of a phase 3 study of intramuscular administration of alefacept in patients with chronic plaque psoriasis
-
Ortonne JP (2003) Clinical response to alefacept: results of a phase 3 study of intramuscular administration of alefacept in patients with chronic plaque psoriasis. J Eur Acad Dermatol Venereol 2 (suppl 17):12-16
-
(2003)
J Eur Acad Dermatol Venereol
, vol.2
, Issue.SUPPL. 17
, pp. 12-16
-
-
Ortonne, J.P.1
-
26
-
-
0032845371
-
Clobetasol-17 propionate lotion under hydrocolloid dressing (Duoderm ET) once weekly versus unoccluded clobetasol-17-propionate ointment twice daily in psoriasis: An immunohistochemical study on remission and relapse
-
Van der Vleuten CJ, Van Vlijmen-Willems IM, De Jong EM, Van de Kerkhof PC (1999) Clobetasol-17 propionate lotion under hydrocolloid dressing (Duoderm ET) once weekly versus unoccluded clobetasol-17-propionate ointment twice daily in psoriasis: an immunohistochemical study on remission and relapse. Arch Dermatol Res 291:390-395
-
(1999)
Arch Dermatol Res
, vol.291
, pp. 390-395
-
-
Van der Vleuten, C.J.1
Van Vlijmen-Willems, I.M.2
De Jong, E.M.3
Van de Kerkhof, P.C.4
-
27
-
-
1342347762
-
The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis
-
Vissers WH, Berends M, Muys L, Van Erp PE, De Jong EM, Van de Kerkhof PC (2004) The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis. Exp Dermatol 13:106-112
-
(2004)
Exp Dermatol
, vol.13
, pp. 106-112
-
-
Vissers, W.H.1
Berends, M.2
Muys, L.3
Van Erp, P.E.4
De Jong, E.M.5
Van de Kerkhof, P.C.6
-
29
-
-
3042697256
-
Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late
-
Vissers WH, Arndtz CH, Muys L, Van Erp PE, de Jong EM, van de Kerkhof PC (2004) Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late. Br J Dermatol 150:852-859
-
(2004)
Br J Dermatol
, vol.150
, pp. 852-859
-
-
Vissers, W.H.1
Arndtz, C.H.2
Muys, L.3
Van Erp, P.E.4
de Jong, E.M.5
van de Kerkhof, P.C.6
|